FDA to Review Schedule 1 Status for Cannabis
• Next News NetworkThe Food and Drug Administration will review the status of cannabis as a schedule 1 drug. A request for a review was filed with the agency by the Drug Enforcement Administration. The FDA still considers cannabis to have no medical benefit. Howeve
